Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
Holding ARWR?
Track your performance easily

Arrowhead Pharmaceuticals (ARWR) Ownership - Who Owns Arrowhead Pharmaceuticals?

1,427 Followers

Arrowhead Pharmaceuticals (ARWR) Ownership Overview

4.46%20.57%1.99%25.20%47.78%
1.99% Other Institutional Investors
25.20% ETFs
47.78% Public Companies and
Individual Investors
The ownership structure of Arrowhead Pharmaceuticals (ARWR) stock is a mix of institutional, retail, and individual investors. Approximately 47.76% of the company’s stock is owned by Institutional Investors, 4.46% is owned by Insiders, and 47.78% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Apr 03, 2024
James C Hamilton
Chief Discovery/trans Medicine
xxxxxxxxxxxxx
$168180
Mar 20, 2024
Hongbo Lu
Director
xxxxxxxxxxxxx
$82990
Mar 08, 2024
xxxxxxxxxxxxx
$1407600
Nov 22, 2023
xxxxxxxxxxxxx
$567315

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
13,871,078Institution11.16%303,637,897
11,580,466Institution9.32%253,496,401
10,194,348Institution8.20%223,154,278
4,139,000Institution3.33%90,602,710
4,058,184Institution3.26%88,833,648
3,715,048Insider2.99%81,322,401
1,446,784Institution1.16%31,670,102
1,422,566Institution1.14%31,139,970
1,331,081Institution1.07%29,137,363
1,195,775Institution0.96%26,175,515

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,194,348Institution8.20%223,154,278
1,446,784Institution1.16%31,670,102
1,422,566Institution1.14%31,139,970
1,331,081Institution1.07%29,137,363
1,195,775Institution0.96%26,175,515
820,242Institution0.66%17,955,097
810,310Institution0.65%17,737,686
694,370Institution0.56%15,199,759
606,280Institution0.49%13,271,469
539,707Institution0.43%11,814,186

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,933,483Institution3.16%84,137,201
3,364,205Institution2.71%79,798,943
3,703,465Institution2.98%71,736,117
3,257,781Institution2.62%71,312,826
2,952,870Institution2.38%57,197,092
2,007,542Institution1.61%42,941,323
1,887,269Institution1.52%36,556,401
1,630,263Institution1.31%31,578,194
1,071,142Institution0.86%23,447,298
996,014Institution0.80%21,802,746

FAQ

Who Owns Arrowhead Pharmaceuticals (ARWR)?
According to the latest TipRanks data, approximately 1.99% of the company's stock is held by institutional investors, 4.46% is held by insiders, and 47.78% is held by retail investors.
    What percentage of Arrowhead Pharmaceuticals (ARWR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.99% of Arrowhead Pharmaceuticals (ARWR) stock is held by institutional investors.
      What percentage of Arrowhead Pharmaceuticals (ARWR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 47.78% of Arrowhead Pharmaceuticals (ARWR) stock is held by retail investors.
        Who owns the most shares of Arrowhead Pharmaceuticals (ARWR)?
        iShares owns the most shares of Arrowhead Pharmaceuticals (ARWR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis